Subscribe
Sign In
Continue to Site
»
Site will load in
15
seconds
Continue to Site »
X
Cannabis Rescheduling: Page 3
Cannabis Industry Reacts to Biden’s Rescheduling Announcement
The President’s May 16 announcement is being touted as an important and historic first step, but many industry constituents say there’s still a long way to go, with social justice at the heart of pushes for decriminalization. Here are reactions from cannabis business executives, industry organizations, lawyers and members of Congress.
White House Moves to Reschedule Cannabis in ‘Monumental’ Decision, Biden Says
The Department of Justice will issue a notice of proposed rulemaking to reclassify cannabis in the Federal Register, which will be followed by a 60-day public comment period prior to the department potentially finalizing the rule.
Cannabis Rescheduling: Where Do We Go From Here?
The legal team at Vicente addressed the significance of the potential move to reschedule cannabis, detailing the ramifications for state-legal cannabis businesses and what could happen next, during a webinar. Here are 12 key takeaways from the event.
Blumenauer Unveils Legislative Blueprint, Additional Administrative Action Needed Following Rescheduling
Congressman Earl Blumenauer, founder and co-chair of the Congressional Cannabis Caucus, demands Biden-Harris Administration use “every power available to them” to build on rescheduling.
Cannabis Rescheduling FAQ: What Now?
From potential timelines to 280E to SAFER Banking, legal experts explain the implications of the federal government reclassifying cannabis as a less dangerous substance.
Former Deputy Attorney General James Cole Weighs in on Cannabis Rescheduling and What’s Next
Cole spoke on a media call organized by industry groups and said Congress must ‘act to create a unified regulatory environment that involves both the states and the federal government.’
Senate Democrats Introduce Bill to Federally Legalize Cannabis
The Cannabis Administration and Opportunity Act aims to deschedule marijuana by removing it from the Controlled Substances Act.
Cannabis Rescheduling Reactions Mixed: While Some Applaud Potential, Others Push For More
Executives, lawmakers and nonprofit leaders weigh in on the significance and shortcomings of the DEA's move to reclassify cannabis as a less dangerous substance.
UPDATE: DEA Moves to Reschedule Cannabis
The federal agency that has long enforced prohibition aligns with the recommendation from the U.S. Department of Health and Human Services, FDA to reclassify cannabis as a Schedule III substance under the Controlled Substances Act.
Cannabis Rescheduling Update: Is a ‘Notoriously Secretive Agency’ Now Involved?
A report that HHS requested an opinion from the Department of Justices’ Office of Legal Counsel raises new questions and concerns. Attorney Shane Pennington explains why that request and the outcome would be crucial to the schedule review process and the industry’s future.
21 US Lawmakers Express Frustration With DEA’s Inaction on Cannabis Rescheduling
The 11 senators and 10 House representatives urged for swift action to remove cannabis from a Schedule I listing in a new letter.
The State of Federal Cannabis Reform Leads CBT’s Most-Read Articles in April
4/20 deals and events, California tax defaults, and nationwide municipal opt outs also highlighted Cannabis Business Times’ most popular stories this month.
Previous Page
Page 3 of 9
Next Page